vs

Side-by-side financial comparison of CHOICEONE FINANCIAL SERVICES INC (COFS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $42.9M, roughly 1.9× CHOICEONE FINANCIAL SERVICES INC). On growth, CHOICEONE FINANCIAL SERVICES INC posted the faster year-over-year revenue change (76.4% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 15.0%).

ChoiceOne Financial Services Inc is a US regional financial holding company that operates through its banking subsidiary, offering personal and commercial banking products including savings accounts, loans, wealth management, and insurance services primarily to consumers, small businesses, and corporate clients across Michigan.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

COFS vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.9× larger
PRCT
$83.1M
$42.9M
COFS
Growing faster (revenue YoY)
COFS
COFS
+56.2% gap
COFS
76.4%
20.2%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
15.0%
COFS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COFS
COFS
PRCT
PRCT
Revenue
$42.9M
$83.1M
Net Profit
$-31.6M
Gross Margin
64.9%
Operating Margin
39.1%
-4.1%
Net Margin
-38.1%
Revenue YoY
76.4%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$1.43
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COFS
COFS
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$42.9M
$76.4M
Q3 25
$61.8M
$83.3M
Q2 25
$60.4M
$79.2M
Q1 25
$44.9M
$69.2M
Q4 24
$24.3M
$68.2M
Q3 24
$36.6M
$58.4M
Q2 24
$34.0M
$53.4M
Net Profit
COFS
COFS
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$14.7M
$-21.4M
Q2 25
$13.5M
$-19.6M
Q1 25
$-13.9M
$-24.7M
Q4 24
$-18.9M
Q3 24
$7.3M
$-21.0M
Q2 24
$6.6M
$-25.6M
Gross Margin
COFS
COFS
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
COFS
COFS
PRCT
PRCT
Q1 26
-4.1%
Q4 25
39.1%
-40.6%
Q3 25
29.6%
-27.8%
Q2 25
27.6%
-28.0%
Q1 25
-39.2%
-39.7%
Q4 24
36.1%
-28.9%
Q3 24
25.4%
-38.4%
Q2 24
24.0%
-50.3%
Net Margin
COFS
COFS
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
23.7%
-25.7%
Q2 25
22.4%
-24.7%
Q1 25
-31.0%
-35.8%
Q4 24
-27.6%
Q3 24
20.1%
-35.9%
Q2 24
19.4%
-48.0%
EPS (diluted)
COFS
COFS
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$1.43
$-0.54
Q3 25
$0.97
$-0.38
Q2 25
$0.90
$-0.35
Q1 25
$-1.29
$-0.45
Q4 24
$0.79
$-0.34
Q3 24
$0.85
$-0.40
Q2 24
$0.87
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COFS
COFS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$88.0M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$465.4M
$347.7M
Total Assets
$4.4B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COFS
COFS
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$88.0M
$286.5M
Q3 25
$99.0M
$294.3M
Q2 25
$156.3M
$302.7M
Q1 25
$139.4M
$316.2M
Q4 24
$96.8M
$333.7M
Q3 24
$145.9M
$196.8M
Q2 24
$101.0M
$214.1M
Total Debt
COFS
COFS
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
COFS
COFS
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$465.4M
$365.9M
Q3 25
$449.6M
$380.3M
Q2 25
$431.8M
$385.8M
Q1 25
$427.1M
$389.2M
Q4 24
$260.4M
$402.2M
Q3 24
$247.7M
$241.2M
Q2 24
$214.5M
$251.8M
Total Assets
COFS
COFS
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$4.4B
$508.1M
Q3 25
$4.3B
$511.5M
Q2 25
$4.3B
$513.1M
Q1 25
$4.3B
$519.4M
Q4 24
$2.7B
$534.0M
Q3 24
$2.7B
$374.1M
Q2 24
$2.7B
$374.4M
Debt / Equity
COFS
COFS
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COFS
COFS
PRCT
PRCT
Operating Cash FlowLast quarter
$31.8M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
58.7%
Capex IntensityCapex / Revenue
15.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COFS
COFS
PRCT
PRCT
Q1 26
Q4 25
$31.8M
$-10.3M
Q3 25
$15.3M
$-6.6M
Q2 25
$9.0M
$-15.0M
Q1 25
$-6.5M
$-17.0M
Q4 24
$47.1M
$-32.4M
Q3 24
$-7.4M
$-18.8M
Q2 24
$15.7M
$-15.7M
Free Cash Flow
COFS
COFS
PRCT
PRCT
Q1 26
Q4 25
$25.2M
$-12.2M
Q3 25
$13.7M
$-9.5M
Q2 25
$6.9M
$-17.8M
Q1 25
$-7.3M
$-18.8M
Q4 24
$45.4M
$-33.6M
Q3 24
$-7.6M
$-19.0M
Q2 24
$15.3M
$-16.8M
FCF Margin
COFS
COFS
PRCT
PRCT
Q1 26
Q4 25
58.7%
-15.9%
Q3 25
22.1%
-11.4%
Q2 25
11.4%
-22.5%
Q1 25
-16.3%
-27.2%
Q4 24
186.4%
-49.2%
Q3 24
-20.8%
-32.6%
Q2 24
44.8%
-31.4%
Capex Intensity
COFS
COFS
PRCT
PRCT
Q1 26
Q4 25
15.4%
2.4%
Q3 25
2.6%
3.4%
Q2 25
3.4%
3.5%
Q1 25
1.9%
2.7%
Q4 24
7.0%
1.7%
Q3 24
0.7%
0.4%
Q2 24
1.4%
2.0%
Cash Conversion
COFS
COFS
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.04×
Q2 25
0.66×
Q1 25
Q4 24
Q3 24
-1.00×
Q2 24
2.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COFS
COFS

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons